GSK is expected to report earnings to fall 48.36% to 66 cents per share on July 27
Q2'22
Est.
$0.67
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.16
Q4'23
Est.
$0.74
The last earnings report on October 30 showed earnings per share of $1.29, beating the estimate of $1.15. With 995.47K shares outstanding, the current market capitalization sits at 88.13B.